Cargando…
Targeting HMGA protein inhibits retinoblastoma cell proliferation
We describe a novel synthetic strategy for conjugating HMGA2 siRNA and the HMGA aptamer to the nucleolin aptamer and nucleolin antibody, respectively. Our studies demonstrate that these conjugates inhibit cell proliferation in retinoblastoma cells.
Autores principales: | Balachandran, Akilandeswari, Zambre, Ajit, Kainth, Jagjot Singh, Nagarajha Selvan, Lakshmi Dhevi, Parameswaran, Sowmya, Afrasiabi, Zahra, Krishnakumar, Subramanian, Kannan, Raghuraman, Upendran, Anandhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085636/ https://www.ncbi.nlm.nih.gov/pubmed/35548247 http://dx.doi.org/10.1039/c8ra06026f |
Ejemplares similares
-
Targeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown
por: Srikar, R., et al.
Publicado: (2016) -
Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases
por: Selvan, Lakshmi Dhevi Nagarajha, et al.
Publicado: (2018) -
Non-coding and Coding Transcriptional Profiles Are Significantly Altered in Pediatric Retinoblastoma Tumors
por: Rajasekaran, Swetha, et al.
Publicado: (2019) -
Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX
por: Maradani, Bhavani Shankar, et al.
Publicado: (2022) -
Clinical relevance of B7H3 expression in retinoblastoma
por: Ganesan, Bhuvaneswari, et al.
Publicado: (2020)